Dockets Home | Accessibility | Dockets Contacts and Location | Operating Status | Item Codes
DOCKETS ENTERED on 3/19/03
Docket Number - Title
ANS 2 John M. Taylor, III to J. David Ash, Esq Vol#: 1
LET 13 Christopher B. Mead Vol#: 1
97P-0130 Require Percentage Ingredient Labeling
C 165 JoAnn Witt Vol#: 5
C 166 Judith Watson Vol#: 5
C 167 John J. Saemann Vol#: 5
C 168 Ms. Meg Neustadt Vol#: 5
C 169 Peggy Lane Vol#: 5
00E-1234 Patent Extension for SONATA (zalepon) #4,626,538
AAV 1 US Patent & Trademark Office Vol#: 1
00E-1237 Patent Extension for Relenza (zanamivir), # 5,360,817
AAV 1 US Patent & Trademark Office Vol#: 1
00E-1345 Patent Extension ACTOS, No. 4,687,777
AAV 1 US Patent & Trademark Office Vol#: 1
00N-1571 Enrofloxacin for Poultry: Opportunity for Hearing
00P-1322 Food Labeling and Allergen Contamination Control
C 513 Anna Greenleaf Vol#: 29
C 514 Melinda L. Miller Vol#: 29
C 515 Limor Weisberg Vol#: 29
C 516 Catrina Popelier, RN, BSN Vol#: 29
C 517 Sheila Renda Springs Vol#: 29
C 518 The Enger Family Vol#: 29
C 519 David Kaplowitz, MD Vol#: 29
C 520 Joan Dunlap Vol#: 29
C 521 Anne Donath Vol#: 29
C 522 Baptisy Health Center Vol#: 29
C 523 Georgetta Hare Vol#: 29
C 524 Sheila Renda Springs Vol#: 29
01E-0362 Patent Term Extension Application, TRAVATAN No. 5,889,052
AAV 1 US Patent & Trademark Office Vol#: 1
02H-0443 Civil Money Penalty Re: LaHaye Ctr.for Advanced Eye Care
CS 5 HFA-305 Vol#: 1
OR 4 HF-3 Vol#: 1
02N-0204 Bar Code Label Requirements for human drug products
NPR 1 Vol#: 8
02N-0528 Risk Management Workshop, April 9-11, 2003 [PDUFA III]
APE 4 Pharmaceutical Safety Assessments, Inc. Vol#: 1
SUP 1 Pharmaceutical Safety Assessments, Inc. Vol#: 1
02P-0469 ANDA for Brimonidine Tartrate Ophthalmic Solution 0.2%